van Putten J P, Krans H M
Biochem Pharmacol. 1986 Jul 1;35(13):2141-4. doi: 10.1016/0006-2952(86)90583-6.
Studies were carried out to determine the role of sulfonylureas in the regulation of insulin-sensitive hexose uptake in cultured 3T3 adipocytes. Exposure (0-72 hr) of cells to the sulfonylurea-derivative tolbutamide (0.05-0.3 mg/ml) induced a time- and concentration-dependent potentiation of the stimulatory effect of insulin on hexose uptake (500 vs 340%). The effect was maximal within 24 hr and completely reversible. It was strictly limited to the presence of insulin. Basal hexose uptake and insulin binding were not affected by the drug. High concentrations of the agent (greater than 0.3 mg/ml) induced a decrease in insulin response, suggesting a concentration optimum. Lineweaver-Burk analysis of uptake data revealed that the potentiating effect of tolbutamide was due to enhancement of the insulin-induced increase in apparent Vmax, i.e. in the number or activity of hexose transporters. This enhancement was inhibited by cycloheximide (1 microgram/ml), indicating involvement of protein synthesis in the induction of the effect. It is concluded that sulfonylureas act by influencing synthesis of protein(s) which potentiate the effect of insulin on hexose uptake.
开展了多项研究以确定磺脲类药物在调节培养的3T3脂肪细胞中胰岛素敏感性己糖摄取方面的作用。将细胞暴露于磺脲类衍生物甲苯磺丁脲(0.05 - 0.3毫克/毫升)中(0 - 72小时),可诱导胰岛素对己糖摄取的刺激作用呈时间和浓度依赖性增强(500%对340%)。该效应在24小时内达到最大值且完全可逆。它严格依赖于胰岛素的存在。基础己糖摄取和胰岛素结合不受该药物影响。高浓度的该药物(大于0.3毫克/毫升)会导致胰岛素反应降低,表明存在最佳浓度。对摄取数据进行的Lineweaver - Burk分析表明,甲苯磺丁脲的增强作用是由于胰岛素诱导的表观Vmax增加,即己糖转运蛋白数量或活性增加。这种增强作用被放线菌酮(1微克/毫升)抑制,表明蛋白质合成参与了该效应的诱导。得出的结论是,磺脲类药物通过影响蛋白质合成来发挥作用,这些蛋白质可增强胰岛素对己糖摄取的作用。